Cargando...

Targeting the alternative NF-κB pathway in pancreatic cancer: a new direction for therapy?

Pancreatic cancer, due to its late diagnosis, is difficult to treat. In addition, current therapy options are insufficient and new approaches for combination treatment are required. Recent demonstration of the importance of constitutive signaling of NF-κB-inducing kinase (NIK, also named MAP3K14) in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Storz, Peter
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3800143/
https://ncbi.nlm.nih.gov/pubmed/23617340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/era.13.28
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!